Image
23.12.2024
NICE approves tirzepatide (Mounjaro) for treating obesity but access t...
NICE (the National Institute for Health and Care Excellence) have now approved tirzepatide (also known by...
In our January research highlights, we look at new research into how AI-powered screening could spot type 2 diabetes risk years in advance, and a new study into genetically altered beta cell therapy tested in type 1 diabetes.
Read more